Safe eye surgery depends on the skill and expertise of the surgeons involved.
Mr Mearza, our clinical director and lead surgeon has a keen interest in clinical research and has over 30 publications in the peer reviewed literature.
His publications range from case reports, book chapters, clinical reviews and studies looking at new techniques and technologies.
Mr Mearza is an internationally recognised speaker and has presented his work at the UK, European as well as the American Society of Cataract & Refractive Surgeons, the American Academy of Ophthalmologists and the Association of Research and Vision in Ophthalmology forums.
He is regularly invited to speak at international conferences as a renowned surgeon and expert voice in his field.
Visit our Blog to keep up to date with the most recent presentations as well as informative articles about vision correction.
LASIK laser eye surgery
At the forefront of developments in technology, Mr Mearza published a study evaluating and comparing modern excimer lasers used in laser vision correction.
He was the first surgeon to publish results of LASIK laser eye surgery using a combination of the Ziemer femtosecond laser and the Wavelight Allegretto excimer laser, two of the most technologically advanced lasers available on the market today. The published results are amongst the best in the world for laser vision correction.
Out of 887 short-sighted (myopic) eyes undergoing laser eye surgery treatment, 96.9% of eyes achieved 20/20 vision after the operation. When both eyes were considered together, 100% achieved 20/20 vision after their laser vision correction surgery.
There were no significant complications with any of the patients treated either during the operation or after surgery.
In 2007, Mr Mearza published the first UK series of patients undergoing a new partial thickness corneal transplantation technique (endothelial keratoplasty).
He also presented the results at the American Academy of Ophthalmology Meeting in the USA.
The technique has since been modified further and Mr Mearza is amongst an elite group of surgeons who offer the new and improved technique which allows for faster visual recovery and healing.
The new technique called “DMEK” involves transplanting a 15 micron thick piece of tissue into the eye. You can watch a shortened version of the DMEK corneal transplantation technique to understand more about this procedure.
Artificial Iris Implants
Mr Mearza is a world expert in the removal of artificial iris implants. These are non-CE marked and non-FDA approved products, making them illegal in the UK. They have caused considerable harm to a number of patients.
Mr Mearza has published numerous articles both in the peer reviewed literature, ophthalmic press and National Press about these implants and their risks.
He has also been featured on television discussing the danger of these implants and his You Tube channel showing footage of his removal technique for these implants has over 240,000 views to date.
Our Clinical Director and Lead surgeon acts as a Medical Monitor and Principal Investigator for various industry sponsored trials looking at new drugs and treatment modalities in ophthalmology. He has a strong collaboration with the Ophthalmic Technology Group-International (OTGi), a full service Clinical Research Organisation (CRO) dedicated to ophthalmic research.
As clinical director of ophthalmology at Imperial College NHS Trust, Mr Mearza actively promotes research within the eye department through the Imperial College Ophthalmic Research Group (ICORG). This is a dedicated clinical trials unit within Imperial solely focused on research within ophthalmology.